Skip to content
Screener

Deferred Revenue at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$684.8M+42.1%
Regenxbio logo
RegenxbioRGNX
$9.88M-29.3%
Prime Medicine logo
Prime MedicinePRME
$7.93M-4.6%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$360K-58.4%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$13.21M-53.3%
Septerna, Inc. logo
Septerna, Inc.SEPN
$60.35M

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.18B+85.4%
Enterprise value$1.18B+71.1%
P/S14.9×-2.0×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeCurrent.

The source filing: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 8:30 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-060739
Line itemMarch 31, 2026December 31, 2025
Accrued expenses25,23932,893
Lease obligations - operating leases, current2,2212,851
Lease obligations - finance leases, current3938
Deferred revenue - related party, current1,9961,776
Note payable, net, current24,86624,648
Other current liabilities105,10850,283
Total Current Liabilities176,127122,555
Deferred revenue - related party64,84065,120

Item 1. Financial Statements (Unaudited)

FAQ

What is MeiraGTx Holdings plc's deferred revenue?
MeiraGTx Holdings plc (MGTX) reported deferred revenue of $2M in Q1 2026.
How has MeiraGTx Holdings plc's deferred revenue changed year-over-year?
MeiraGTx Holdings plc's deferred revenue decreased by 52.9% year-over-year, from $4.24M to $2M.
What is the long-term trend for MeiraGTx Holdings plc's deferred revenue?
Over 3 years (2022 to 2025), MeiraGTx Holdings plc's deferred revenue has grown at a -51.0% compound annual growth rate (CAGR), from $15.12M to $1.78M.
What does deferred revenue mean?
Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.

Ask your AI about MeiraGTx Holdings plc's deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude